Ovarian Cancer Therapy
Research from University of Athens provide new insights into ovarian cancer therapy
Published in Oncology Business Week, December 14th, 2008
Scientists discuss in 'Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol' new findings in ovarian cancer. According to recent research published in the journal Biological Chemistry, "We assessed changes in the apoptosis-related genes BCL2, BAX, BCL2L12, FAS and CASPASE-3 in OVCAR-3 human ovarian cancer cells and BT-20 human breast cancer cells to provide an insight into the molecular mechanisms involved in the response of these cells to treatment with anticancer drugs and to assess their value as potential biomarkers of chemotherapy response in breast and ovarian cancer....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- America TeVe
Pellizcame Que Estoy Bailando from America TeVe Becomes the Most Entertaining Choice for a Good Cause in South Florida - Angiogenesis
AngioGenex Reviews 2008 Achievements and Sets Goals for 2009 - ArQule, Inc.
ArQule, Inc. to Present at Lazard Capital Markets Healthcare Conference - Biotechnology
MICROFLUIDICS INTRODUCES WIDE RANGE OF MICROFLUIDIZERŽ PROCESSORS FOR PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES Aseptic, Enhanced, and Basic Models Meet Industry-Specific Needs - Breast Cancer
First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama - Breast Cancer
Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
